GenEmbryomics sequences the genomes of IVF embryos
MedTech Actuator startup GenEmbryomics offers an innovative new technique for IVF patients to screen for every known genetic disease before pregnancy.
“We are the first to develop and offer as a service IVF embryo genome sequencing and screening for every genetic disease,” says Nick Murphy, GenEmbryomics Founder and CEO.
Nick and team became aware of patients undergoing their long and arduous IVF journey, then discovering that their baby had a genetic disease.
“We knew that we could pick up these genetic diseases using our genome sequencing technique,” says Nick.
Current tests available to patients are comparable in cost to GenEmbryomics. However they are limited in scope of genetic diseases that they identify, while GenEmbryomics enables patients to screen for every known genetic disease.
“The GenEmbryomics technique of sequencing and screening the entire genome out-performs the currently used tests,” says Nick.
“GenEmbryomics provides IVF patients with peace-of-mind that they can have children without the burden of genetic disease.”
MedTech Actuator Accelerator x GenEmbryomics
The MedTech Actuator’s specialised acceleration model surrounds startups with the ecosystem support they need to bring their MedTech, HealthTech or BioTech innovation to the patients and clinicians who need it most.
Through the MedTech Actuator Accelerator’s intensive mentorship, industry collaboration, up to AUD$200K initial capital injection and capital raising support, founders can achieve in 12 months what can typically take 3 years or more.
GenEmbryomics is based in Melbourne and joined MedTech Actuator in 2021 to develop a market ready company by the end of the program.
“With MedTech Actuator’s knowledge and experience we’ve been shaped to make this achievement realisable,” says Nick.
A major milestone for GenEmbryomics was connecting with keen investors.
“MedTech Actuator prepares companies to take on investment – we were ready to engage when investment discussions began.”
Nick notes that MedTech, BioTech and HealthTech startups require an array of specialist skills and resources.
“The MedTech Actuator Accelerator is comprehensive and helped GenEmbryomics to develop in the specialist areas we needed. This support was crucial in preparing us for the reality of the life sciences industry.”
Nick would not hesitate in recommending the MedTech Actuator Accelerator to MedTech, BioTech and HealthTech startups with a prototype or proof-of-concept.
“The MedTech Actuator Accelerator has been a fundamental contributor to our progress and traction. They always go the extra 100 miles – and are wonderful people!”
Join the next MedTech Actuator Accelerator intake.
Do you have a MedTech, HealthTech or BioTech prototype or proof-of-concept to improve or save lives? Get ready to take your innovation further, faster in 2022 with our new MedTech Actuator Accelerator cohort – Download the information pack or book office hours with our team to discuss your application.
The MedTech Actuator Accelerator is supported by LaunchVic and the REDI Initiative, powered by MTPConnect.